Literature DB >> 23117471

Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit.

Jason A Trubiano1, Bradley Gardiner, Jason C Kwong, Peter Ward, Adam G Testro, Patrick G P Charles.   

Abstract

We describe a case of faecal microbiota transplantation (FMT) used for severe binary toxin-positive Clostridium difficile infection in an intensive care setting. The patient was admitted to the ICU of a tertiary hospital and failed traditional maximal pharmacological management. Adjunctive therapy with FMT given through gastroscopy resulted in resolution of the C. difficile-related symptoms. Although there is a growing experience with FMT for recurrent C. difficile infection, published evidence in severe disease is very limited. In a landscape of increasingly severe C. difficile infection, adjunctive FMT may be considered a useful early treatment option.

Entities:  

Mesh:

Year:  2013        PMID: 23117471     DOI: 10.1097/MEG.0b013e32835b2da9

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  18 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 2.  Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

Authors:  Colleen R Kelly; Stacy Kahn; Purna Kashyap; Loren Laine; David Rubin; Ashish Atreja; Thomas Moore; Gary Wu
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

Review 3.  Fecal microbiota transplantation for the management of Clostridium difficile infection.

Authors:  Krishna Rao; Vincent B Young
Journal:  Infect Dis Clin North Am       Date:  2015-03       Impact factor: 5.982

4.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 5.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

6.  Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection.

Authors:  Hadeel Zainah; Mona Hassan; Laila Shiekh-Sroujieh; Syed Hassan; George Alangaden; Mayur Ramesh
Journal:  Dig Dis Sci       Date:  2014-07-23       Impact factor: 3.199

Review 7.  Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.

Authors:  Alexander Khoruts; Alexa R Weingarden
Journal:  Immunol Lett       Date:  2014-08-10       Impact factor: 3.685

Review 8.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection.

Authors:  Krishna Rao; Nasia Safdar
Journal:  J Hosp Med       Date:  2015-09-07       Impact factor: 2.960

9.  Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity.

Authors:  J C Kwong; K Urbancic; J A Trubiano
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 10.  Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies.

Authors:  Zeina Z Berro; Righab H Hamdan; Israa H Dandache; Mohamad N Saab; Hussein H Karnib; Mahmoud H Younes
Journal:  BMC Infect Dis       Date:  2016-05-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.